Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a

Hepatology. 1993 Dec;18(6):1516-21.


Human anaphylatoxin C3a increases glycogenolysis in perfused rat liver. This action is inhibited by prostanoid synthesis inhibitors and prostanoid antagonists. Because prostanoids but not anaphylatoxin C3a can increase glycogenolysis in hepatocytes, it has been proposed that prostanoid formation in nonparenchymal cells represents an important step in the C3a-dependent increase in hepatic glycogenolysis. This study shows that (a) human anaphylatoxin C3a (0.1 to 10 micrograms/ml) dose-dependently increased prostaglandin D2, thromboxane B2 and prostaglandin F2 alpha formation in rat liver macrophages (Kupffer cells); (b) the C3a-mediated increase in prostanoid formation was maximal after 2 min and showed tachyphylaxis; and (c) the C3a-elicited prostanoid formation could be inhibited specifically by preincubation of C3a with carboxypeptidase B to remove the essential C-terminal arginine or by preincubation of C3a with Fab fragments of a neutralizing monoclonal antibody. These data support the hypothesis that the C3a-dependent activation of hepatic glycogenolysis is mediated by way of a C3a-induced prostanoid production in Kupffer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Complement C3a / pharmacology*
  • Dinoprost / biosynthesis
  • Glycogen / metabolism
  • Humans
  • Kupffer Cells / metabolism*
  • Liver / cytology*
  • Liver / enzymology
  • Liver / metabolism
  • Phosphorylases / metabolism
  • Prostaglandin D2 / biosynthesis
  • Prostaglandins / biosynthesis*
  • Rats
  • Superoxides / metabolism
  • Thromboxane B2 / biosynthesis
  • Time Factors


  • Prostaglandins
  • Superoxides
  • Thromboxane B2
  • Complement C3a
  • Glycogen
  • Dinoprost
  • Phosphorylases
  • Prostaglandin D2